January 2017 PMID 27737437

Association Between Androgen Deprivation Therapy and Risk of Dementia.

Kevin T Nead, Greg Gaskin, Cariad Chester, Samuel Swisher-McClure, Nicholas J Leeper, Nigam H Shah

Download social card

Mentions

187

Peak: 4 in Aug 2021

across 6 sources since Jul 2019

Extended reach

586,242

potential audience

Total likes

13,976

Video views

524,327

Mentions per month

Jul 2019 – Apr 2025

Where it's discussed

News143 articles
Facebook24 posts
X / Twitter9 posts
Blogs5 articles
YouTube4 videos
Reddit2 posts

AI synopsis

What people are saying

The overall tone of these discussions reflects a strong acknowledgment of the research, with examples like references to reading the study on research platforms and highlighting key findings. The words used, such as 'new article' and hashtags like '#prostatecancer,' demonstrate active interest, though the interactions mostly remain at a preliminary sharing level rather than deep analysis or debate.

AgreementModerate agreement

Most discussions acknowledge the study’s findings, indicating a general agreement on the link between ADT and increased dementia risk.

InterestHigh interest

The use of phrases like 'new article' and hashtags suggests active interest among professionals and advocates in the topic.

EngagementModerate engagement

Comments such as 'Read it on...' and mentions of sharing the research show moderate engagement, but few delve into detailed implications or critique.

ImpactModerate impact

While the study is recognized as important, discussions largely focus on awareness and dissemination rather than profound policy or clinical changes.

Abstract in brief

The study found that using androgen deprivation therapy (ADT) for prostate cancer is linked to a higher risk of developing various types of dementia, including Alzheimer’s disease.
Researchers analyzed medical records of over 9,200 men diagnosed with prostate cancer, and those who received ADT had about a 2.17 times higher chance of developing dementia compared to those who did not receive ADT.
The increased risk was most prominent in men who used ADT for at least 12 months, and the absolute risk of developing dementia after 5 years was 44% in the ADT group versus 35% in the non-ADT group.

Read the full abstract

All mentions

Reevaluating Prostate Biopsy: Risks, Benefits, and Alternatives

Prostate biopsies may cause more harm than good, including complications and cancer spread. Many prostate cancers are nonaggressive, so understanding safer, evidence-based monitoring options is essential for informed…

Intellectual Medicine · Mar 18, 2025 347,136 views

Reevaluating PSA Management to Prevent Unnecessary Prostate Biopsies

Managing an Elevated PSA and avoiding unnecessary prostate biopsies. Dr. Stephen Petteruti discusses when a measured approach is best, highlighting alternatives like advanced imaging and lifestyle changes to support…

Intellectual Medicine · Apr 8, 2025 85,751 views

Rethinking Prostate Biopsy and Treatment Strategies for Early Cancer

This episode examines the risks behind traditional PSA tests and prostate biopsies, challenging conventional protocols. Dr. Stephen Petteruti explores alternative approaches to prostate health, emphasizing proactive…

Intellectual Medicine · Apr 1, 2025 75,711 views

Prostate Cancer Management: Reassessing Treatment Options and Outcomes

The Intellectual Medicine Approach offers a proactive strategy to fight prostate cancer, emphasizing vitality preservation and alternative therapies. This method aims to help men address the disease head-on while…

Intellectual Medicine · Apr 22, 2025 15,729 views

UCL Discovery

@ucl_discovery · X

Open Access UCL Research: Association between Androgen Deprivation Therapy and Risk of Dementia in Men with Prostate Cancer https://t.co/bIf6vFtfaT

Dec 21, 2021 · 2,528 followers View post →

EMR Research papers

@EMR_research · X

Association between Androgen Deprivation Therapy and Risk of Dementia in Men with Prostate Cancer https://t.co/pFyQsjWVKo

Aug 7, 2021 · 206 followers View post →

Paperbirds_Oncology

@PaperbirdsO · X

New article: Association between Androgen Deprivation Therapy and Risk of Dementia in Men with Prostate Cancer https://t.co/r9NyXlMS1j #prostatecancer #oncology https://t.co/B7HGCfnJGz

Aug 7, 2021 · 892 followers View post →

Barbara Bressi

@bressi_barbara · X

RT @costi_stefania: "Association between Androgen Deprivation Therapy and Risk of Dementia in Men with Prostate Cancer" — Read it on @Resea…

Aug 4, 2021 · 1 share · 20 followers View post →

Stefania Costi

@costi_stefania · X

"Association between Androgen Deprivation Therapy and Risk of Dementia in Men with Prostate Cancer" — Read it on @ResearchGate: https://t.co/d1zhELxZwf

Aug 3, 2021 · 1 share · 37 followers View post →

Ramón MD

@ramonphysician · X

RT @JAMAOnc: Association Between Androgen Deprivation Therapy and Risk of Dementia https://t.co/N42xJw8BFP #oncaudio

Feb 24, 2021 · 1 share · 335 followers View post →

JAMA Oncology

@JAMAOnc · X

Association Between Androgen Deprivation Therapy and Risk of Dementia https://t.co/N42xJw8BFP #oncaudio

Feb 24, 2021 · 1 like · 1 share · 49,040 followers View post →

Linda Carney MD

@lindacarneymd · X

https://t.co/3UhVLfUmsu blog: Association Between Androgen Deprivation Therapy and Risk of Dementia. in Dementia. https://t.co/YDVZsez90v https://t.co/avyfzHLAZh

Jul 26, 2019 · 245 followers View post →

青島周一

@syuichiao89 · X

以前にも報告があったのですね。 Association Between Androgen Deprivation Therapy and Risk of Dementia. - PubMed - NCBI https://t.co/wocUes5YR7

Jul 13, 2019 · 8,605 followers View post →